X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


Latest Post

June 13, 2019

Key Takeaways from FDA Public Meeting on Outsourcing Facilities, cGMP and Office Stock

Members of the West Pharmaceutical Services, Inc. (West) Marketing Unit had the pleasure of attending the recent FDA Public Meeting on Tuesday, May 21, 2019 regarding 503B Compounding Pharmacies and the cGMP draft guidance, as well as office stock issues which had generated many comments.
West Pharma

Melanie Prudom

Director, Market Insights, Pharma

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}